We conducted a survival analysis to determine the expression level of MTDH in the cancer tissues, and observed that patients with higher expression of MTDH developed poorer prognosis, while those with lower expression of MTDH had a more satisfactory prognosis (P < 0.001, Fig. 1D). Here, MTDH is linked to cancer.